Argentina shows interest in 2 Cuban vaccines against Covid-19 in Phase III trials

Both the Soberana 2 and Abdala vaccines are in the last phase of clinical trials on the island and are expected to start mass vaccination in July and August.

RIO DE JANEIRO, BRAZIL - Cuban scientists are working on four vaccine candidates against Covid-19: Soberana 1 (in Phase II), Soberana 2 (in Phase III), Mambisa (in Phase I) and Abdala (in Phase III). A fifth candidate, Soberana +, is a reformulation of Soberana 1, intended for convalescents of the disease.

If all trial phases are successfully completed and approval is granted by Cuba's National Regulatory Agency, any of these immunizers would become the . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?